Versant Capital Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.3K | Buy |
2,056
+1,284
| +166% | +$23.9K | 0.01% | 1132 |
|
|
2025
Q1 | $14.8K | Buy |
772
+188
| +32% | +$3.6K | ﹤0.01% | 1508 |
|
|
2024
Q4 | $21K | Buy |
584
+207
| +55% | +$7.46K | ﹤0.01% | 1009 |
|
|
2024
Q3 | $16K | Hold |
377
| – | – | ﹤0.01% | 878 |
|
|
2024
Q2 | $15.2K | Hold |
377
| – | – | ﹤0.01% | 810 |
|
|
2024
Q1 | $13.4K | Hold |
377
| – | – | ﹤0.01% | 647 |
|
|
2023
Q4 | $11.2K | Buy |
377
+370
| +5,286% | +$10.9K | ﹤0.01% | 705 |
|
|
2023
Q3 | $145 | Sell |
7
-35
| -83% | -$725 | ﹤0.01% | 1906 |
|
|
2023
Q2 | $1.03K | Sell |
42
-476
| -92% | -$11.7K | ﹤0.01% | 1590 |
|
|
2023
Q1 | $21K | Buy |
+518
| New | +$21K | 0.01% | 470 |
|
|
2022
Q2 | – | Sell |
-4
| Closed | – | – | 1644 |
|
|
2022
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 1627 |
|
|
2021
Q4 | $1K | Hold |
4
| – | – | ﹤0.01% | 1359 |
|
|
2021
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 1599 |
|
|
2021
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 1595 |
|
|
2021
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 1603 |
|
|
2020
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 1525 |
|
|
2020
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 1500 |
|
|
2020
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 1546 |
|
|
2020
Q1 | $0 | Sell |
4
-7
| -64% | – | ﹤0.01% | 1666 |
|
|
2019
Q4 | $0 | Hold |
11
| – | – | ﹤0.01% | 1578 |
|
|
2019
Q3 | $0 | Buy |
+11
| New | – | ﹤0.01% | 1588 |
|
|
2019
Q2 | – | Sell |
-9
| Closed | – | – | 1693 |
|
|
2019
Q1 | $0 | Buy |
+9
| New | – | ﹤0.01% | 1734 |
|